Injections, Intravenous
Showing 1 - 25 of >10,000
Learn About Study Medicine - Precedex in Children From Japan.
Not yet recruiting
- Sedation
- Dexmedetomidine Hydrochloride
- (no location specified)
Oct 10, 2023
Lower Back Pain, Lumbar Radiculopathy Trial in Baltimore (device, drug, other)
Recruiting
- Lower Back Pain
- Lumbar Radiculopathy
- Virtual reality
- +2 more
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Mar 29, 2022
Healthy Volunteers Trial in Groningen (efgartigimod IV, efgartigimod PH20 SC)
Completed
- Healthy Volunteers
- efgartigimod IV
- efgartigimod PH20 SC
-
Groningen, NetherlandsStudy Site 1
Apr 2, 2021
Intravenous Injections, Vaccination Trial in La Roche-sur-Yon, Le Mans, Nantes (Buzzy® device, EMLAPATCH (lidocaine,
Completed
- Intravenous Injections
- Vaccination
- Buzzy® device
- EMLAPATCH (lidocaine, prilocaine)
-
La Roche-sur-Yon, France
- +2 more
Sep 8, 2021
CNS Pathology Trial in Worldwide (BAY1747846, Gadobutrol (Gadovist/Gadavist))
Completed
- Central Nervous System Pathology
- BAY1747846
- Gadobutrol (Gadovist/Gadavist)
-
Chicago, Illinois
- +17 more
Dec 13, 2022
Healthy Trial in Saint Petersburg (BCD-066, Aranesp)
Completed
- Healthy
- BCD-066
- Aranesp
-
Saint Petersburg, Strelna, Russian FederationBIOCAD
Apr 8, 2020
Chronic Heart Failure, Iron Deficiency, Left Ventricular Systolic Dysfunction Trial in United Kingdom (Ferric Derisomaltose)
Completed
- Chronic Heart Failure
- +2 more
- Ferric Derisomaltose
-
Aberdeen, United Kingdom
- +71 more
Oct 27, 2022
End Stage Renal Disease on Hemodialysis Trial in Beijing, Shijiazhuang (Difelikefalin Injection)
Recruiting
- End Stage Renal Disease on Hemodialysis
- Difelikefalin Injection
-
Beijing, China
- +3 more
Jun 1, 2023
Traumatic Brain Injury Trial (Mesenchymal Stromal Cells (MSC), )
Not yet recruiting
- Traumatic Brain Injury
- Mesenchymal Stromal Cells (MSC)
- placebo
- (no location specified)
Nov 17, 2023
Heart Failure With Reduced Ejection Fraction Trial (Extracellular vesicle-enriched secretome of cardiovascular progenitor cells
Not yet recruiting
- Heart Failure With Reduced Ejection Fraction
- Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells
- (no location specified)
Mar 7, 2023
Regenerative Medicine Trial in Lahore (PRP and PBD-VSEL Stem Cell therapy)
Completed
- Regenerative Medicine
- PRP and PBD-VSEL Stem Cell therapy
-
Lahore, Punjab, Pakistangull e Rukh
Nov 20, 2023
Recurrent Cancer, Primary Cancer, Second Cancer Trial in Lyon (Dostarlimab)
Not yet recruiting
- Recurrent Cancer
- +2 more
-
Lyon, FranceCentre Léon Bérard
May 12, 2023
Knee Osteoarthritis Trial in Belfort, Mulhouse (Intra-articular single injection, Intra-articular three injections)
Recruiting
- Knee Osteoarthritis
- Intra-articular single injection
- Intra-articular three injections
-
Belfort, France
- +1 more
Jan 2, 2023
Primary CNS Lymphoma Trial in Paris (Glucarpidase, Methotrexate (MTX))
Recruiting
- Primary Central Nervous System Lymphoma
- Glucarpidase
- Methotrexate (MTX)
-
Paris, FranceHôpital Pitié-Salpêtrière
Oct 24, 2022
Haemophilia A Trial in China (turoctocog alfa pegol (N8-GP))
Completed
- Haemophilia A
- turoctocog alfa pegol (N8-GP)
-
Beijing, Beijing, China
- +9 more
Feb 2, 2023
Huntington Disease Trial in Guangzhou (ER2001 injection)
Recruiting
- Huntington Disease
- ER2001 injection
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Guangzhou Medical University
Aug 29, 2023
Knee Osteoarthritis Trial in France, Monaco (Medical Device : HO-1, Medical Device : HS-3, Medical Device : SINOVIAL® ONE)
Not yet recruiting
- Knee Osteoarthritis
- Medical Device : HO-1
- +2 more
-
Aix-les-Bains, France
- +38 more
Jul 28, 2023
Melanoma Trial in Worldwide (Pembrolizumab Dose C, Pembrolizumab Dose A, Pembrolizumab Dose B)
Active, not recruiting
- Melanoma
- Pembrolizumab Dose C
- +3 more
-
Orange, New South Wales, Australia
- +14 more
Jan 19, 2023
Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)
Recruiting
- Neuroendocrine Tumors
- Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 19, 2023
Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,
Active, not recruiting
- Relapsing Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Ocrelizumab IV
- +5 more
-
Tampa, Florida
- +46 more
Jan 13, 2023
Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)
Not yet recruiting
- Solid Tumor
- M1-c6v1
-
Kashiwa-shi, Chiba, Japan
- +2 more
Sep 19, 2023
Postpartum Hemorrhage Trial (Tranexamic acid, Placebo)
Not yet recruiting
- Postpartum Hemorrhage
- Tranexamic acid
- Placebo
- (no location specified)
Nov 11, 2022
Anxiety Trial in Samsun (The Vibration Intervention, The Pressure Intervention)
Completed
- Anxiety
- The Vibration Intervention
- The Pressure Intervention
-
Samsun, Atakum, TurkeyHatice Uzşen
Dec 9, 2022